what companies make glp-1 drugs America's Poison Centers The Biggest Winner of GLP-1

doi: 10.1111/dom.15728

Also known as GGG Tri-agonist, GLP-1/GIP/glucagon tri-agonist, or LY3437943, this injectable medication is similar to existing weight loss medications like tirzepatide and semaglutide but has increased efficacy

There have also been documented local skin reactions when using GLP-1 RAs, particularly with the long-acting formulations

A major reason drug sales grew so much the popularity of the weight-loss and diabetes drugs tirzepatide and semaglutide

Diabetes Care 33(2):428433 Eguchi Y, Kitajima Y, Hyogo H, Takahashi H, Kojima M, Ono M et al (2015) Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J)